Metraipolis › archive › dc_5e38552ef1bc
Early C-reactive protein reduction predicts survival in real-world extensive-stage small cell lung cancer treated with first-line adebrelimab-based… — Europe PMC PMID:41267986
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41267986
- DOI
- 10.3389/fonc.2025.1709336
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T19:02:38.882Z
- SHA-256 of the archived text
bc384f04a0860cb5180dded5902273077eb75b05884cf3124cb8101e7c47bd27- Stable URL of this page
https://metraipolis.com/documento/dc_5e38552ef1bc
How to cite
Early C-reactive protein reduction predicts survival in real-world extensive-stage small cell lung cancer treated with first-line adebrelimab-based… — Europe PMC PMID:41267986 — Europe PMC (en), https://europepmc.org/article/MED/41267986 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5e38552ef1bc (Metraipolis archive dc_5e38552ef1bc, sha256 bc384f04a0860cb5180dded5902273077eb75b05884cf3124cb8101e7c47bd27)
BibTeX
@misc{dc5e38552ef1bc,
title = {Early C-reactive protein reduction predicts survival in real-world extensive-stage small cell lung cancer treated with first-line adebrelimab-based… — Europe PMC PMID:41267986},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41267986},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5e38552ef1bc; sha256 bc384f04a0860cb5180dded5902273077eb75b05884cf3124cb8101e7c47bd27},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41267986. Agents can read the archived copy with the MCP tool read_document.